T0	Participants 84 145	chemo-naïve patients with advanced non-small cell lung cancer
T1	Participants 287 337	in chemo-naïve non-small cell lung cancer patients
T2	Participants 339 453	METHODS Patients with chemo-naïve stage IIIB/IV non-small cell lung cancer were randomized into two treatment arms
T3	Participants 650 707	RESULTS A total of 80 patients were entered in this trial